Penn Medicine Provider
Rheumatology
Steffan W. Schulz, MD
4.8
(579)
Accepting new patients
Sees patients age 18 and up
Penn Rheumatology Perelman
View 1 additional location

About me

  • Associate Professor of Clinical Medicine (Rheumatology)

Education and training

  • Medical School: Temple University School of Medicine
  • Residency: Thomas Jefferson University Hospital
  • Fellowship: Thomas Jefferson University Hospital

What my patients think about me

Average Rating
4.8

579 reviews

Comments are submitted by patients and reflect their views and opinions. The comments are not endorsed by and do not necessarily reflect the views of Penn Medicine.

June 2025
5.0
5.0
he is always very helpful
May 2025
5.0
5.0
great doctor
May 2025
5.0
5.0
dr. schulz is knowledgeable and easy to understand and talk to.
May 2025
5.0
5.0
knowledgeable

Insurance accepted

My Locations

Penn Medicine hospital privileges

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
  • Penn Presbyterian Medical Center: Has privileges to treat patients in the hospital.
Dr. Schulz is a Penn Medicine physician.

Qualifications and experience

Treatments and Conditions

My research

Meggan Mackay1, Robert Zurier2, Diane Kamen3, Fotios Koumpouras4, Anca Askanase5, Kenneth C Kalunian6, Steffan Schulz7, Giovanni Franchin8, Nancy Olsen9, Andreea Coca10, Roberto Caricchio11, Maureen McMahon12, Maria Dall’Era13, Amit Saxena14, Megan Clowse15, Stanley Ballou65, Linna Ding17, Beverly Welch17, Jessica Springer17, Andrew Shaw1, Lynette Keyes-Elstein18, Kati Steinmiller18, Amanda Mickey18, Cynthia Aranow1, Betty Diamon A Phase 2, Double-blind, Randomized, Placebo-Controlled Multicenter Study to Evaluate Efficacy, Safety, and Tolerability of JBT-101/Lenabasum in Systemic Lupus Erythematosus, An Autoimmunity Centers of Excellence Study (ALE09) , ACR 2022 national Meeting: 2022


Winetsky DE, Myers J, Schulz S, Tino G, Wilck M. A Case of Cavitary Pulmonary Mycobacterium Avium Intracellulare Infection in the Setting of Leflunomide Treatment. , J Clin Rheumatol, 23(4): 2017,231-232


Costa-Reis P, Russo PA, Zhang Z, Colonna L, Maurer K, Gallucci S, Schulz SW, Kiani AN, Petri M, Sullivan KE The Role of MicroRNAs and Human Epidermal Growth Factor Receptor 2 in Proliferative Lupus Nephritis , Arthritis and Rheumatism , 67(9): 2015,2415-26


Schulz SW, Shenin M, Mehta A, Kebede A, Fluerant M, Derk CT Initial presentation of acute transverse myelitis in systemic lupus erythematosus: demographics, diagnosis, management and comparison to idiopathic cases , Rheumatology International, 32(9): 2012,2623-7


Haija AJ, Schulz SW. The role and effect of complementary and alternative medicine in systemic lupus erythematosus. , Rheum Dis Clin North Am. , 37(1): 2011,47-62


Schulz SW, Bober M, Johnson C, Braverman N, Jimenez SA. Maternal mixed connective tissue disease and offspring with chondrodysplasia punctata. , Semin Arthritis Rheum. , 39(5): 2010,410-6


Derk CT, Grace E, Shenin M, Naik M, Schulz S, Xiong W. A prospective open-label study of mycophenolate mofetil for the treatment of diffuse systemic sclerosis. , Rheumatology (Oxford), 48(12): 2009,1595-9


Schulz SW, O'Brien M, Maqsood M, Sandorfi N, Del Galdo F, Jimenez SA. Improvement of severe systemic sclerosis-associated gastric antral vascular ectasia following immunosuppressive treatment with intravenous cyclophosphamide. , J Rheumatol., 36(8): 2009,1653-6


Schulz SW, Derk CT. Gastrointestinal Manifestation of Systemic Lupus Erythematosus: a survey of literature. , Open Rheumatol J., 1: 2009,10-26


Schulz SW, Derk CT. Systemic sclerosis at the cellular level: molecular pathways of pathogenesis and its implication on future drug design. , Curr Med Chem., 16(30): 2009,3986-95